Immune response activation following hyperthermic intraperitoneal chemotherapy for peritoneal metastases: A pilot study

doi:10.5306/wjco.v11.i6.397

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5853)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

185

WORD

HTML

3486

Figures (1-2)

158

Tables (1-3)

143

Sum=4036

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

594

Download

1223

Sum=1817

Jun 24, 2020 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Clin Oncol. Jun 24, 2020; 11(6): 397-404
Published online Jun 24, 2020. doi: 10.5306/wjco.v11.i6.397

Open in New Tab Full Size Figure Download Figure

Figure 1 Representative example of fluorescence-activated cell sorting immunophenotypic analysis.

Open in New Tab Full Size Figure Download Figure

Figure 2 Median values (absolute value cells/mL) of T helper and T cytotoxic levels at baseline and 30 d after hyperthermic intraperitoneal chemotherapy. HIPEC: Hyperthermic intraperitoneal chemotherapy.

Citation: Fiorentini G, Sarti D, Patriti A, Eugeni E, Guerra F, Masedu F, Mackay AR, Guadagni S. Immune response activation following hyperthermic intraperitoneal chemotherapy for peritoneal metastases: A pilot study. World J Clin Oncol 2020; 11(6): 397-404
URL: https://www.wjgnet.com/2218-4333/full/v11/i6/397.htm
DOI: https://dx.doi.org/10.5306/wjco.v11.i6.397